BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2008
View Archived Issues
FDA requests review of clinical and preclinical safety data relating to IND for Heplisav
Read More
Sirtris reports results from phase Ib clinical trial of resveratrol for type 2 diabetes
Read More
Human Genome Sciences reacquires rights to mapatumumab and lexatumumab from GSK
Read More
Aastrom reports encouraging clinical results for autologous stem cell therapy
Read More
BMS-753493 cytotoxic in folate receptor-positive human tumor cells
Read More
Kosan demonstrates anticancer activity of CRM1-protein inhibition
Read More
SNS-314 induces tumor growth inhibition in xenograft models
Read More
AlphaVax announces initial results from phase I clinical trial of cytomegalovirus vaccine
Read More
Novel antimicrobial compounds imparted in recent patent literature
Read More
Motor improvement with pardoprunox in patients with early-stage PD seen in phase II trial
Read More
Clinical pharmacokinetic profile of XP-13512 reported at the AAN meeting
Read More
Mesoblast reports long-term results from animal trials of allogeneic stem cells for osteoarthritis
Read More
Kipres 5 mg tablets launched in Japan for bronchial asthma and allergic rhinitis
Read More
Amerge launched in Japan for migraine
Read More
Pfizer launches Revatio for PAH in Japan
Read More
Novel agents for treating urinary incontinence disclosed in recent Fujiyakuhin patent
Read More
Recent GSK and Peakdale patents describe new treatment options for endocrine-related disorders
Read More
Asahi Kasei receives approval for Famvir and signs marketing agreement with Maruho
Read More
Recordati submits NDA to FDA for Carbaglu for hyperammonemia due to NAGS deficiency
Read More
ARYx receives FDA clearance for phase I ATI-9242 trial
Read More
FDA grants orphan designation to ARC-1779 for the treatment of TTP
Read More
Initial studies in vivo with A3-APO show bactericidal activity
Read More
Immatics initiates phase I/II study of IMA-910 cancer vaccine in colorectal cancer
Read More
Lorus Therapeutics to examine new administration route for LOR-2040
Read More
Wyeth and Trubion commence phase I SBI-087 trial in rheumatoid arthritis
Read More
FDA approves Cimzia for the treatment of moderate to severe Crohn's disease
Read More